Research & Clinical Trials – Page 6
-
newsResearch & Clinical TrialsMemorial Sloan Kettering Cancer Center in New York City has opened a novel clinical trial that combines the immunotherapy drug Keytruda with…
-
newsResearch & Clinical Trials
New Opdivo/Yervoy Mesothelioma Clinical Trial Begins Soon
A novel clinical trial involving the immunotherapy combination of Opdivo and Yervoy will open soon in Chicago. The goal is to study the… -
newsResearch & Clinical Trials
Study Shows Access to Care Often Difficult for Mesothelioma Patients
When it comes to malignant pleural mesothelioma, not everyone is treated equally. A disparity in access to care makes the difference in… -
newsResearch & Clinical Trials
Mesothelioma Research, COVID Findings Featured at IASLC Conference
Researchers from around the world presented their insights into serious lung health issues, including mesothelioma, during the International Association for the Study of… -
newsResearch & Clinical Trials
Ramucirumab Shows Survival Benefits with Pleural Mesothelioma
Adding the drug ramucirumab to gemcitabine chemotherapy worked especially well in a recent clinical trial involving second-line treatment for patients with… -
newsResearch & Clinical Trials
Study: Pleural Mesothelioma Treatment Effective with Peritoneal Disease
The University of Texas MD Anderson Cancer Center has taken an immunotherapy treatment recently approved by the U.S. Food and Drug Administration… -
newsResearch & Clinical Trials
Researchers Study New Immunotherapy Combination for Mesothelioma
The immunotherapy combination of tremelimumab and durvalumab has shown surprising efficacy, particularly as a second-line treatment option for patients with pleural… -
newsResearch & Clinical Trials
Mesothelioma Olaparib Clinical Trial Targets Genetic Mutation
The mesothelioma program at University of Chicago Medicine is recruiting patients for its latest clinical trial involving olaparib, an oral chemotherapy drug… -
newsResearch & Clinical Trials
Duke Study Suggests Radiation Does Not Extend Mesothelioma Survival
A dual registry analysis by the esteemed Duke University Medical Center has concluded that adjuvant hemithoracic radiation does not improve survival when… -
newsResearch & Clinical Trials
FDA Grants Orphan Drug Designation to Novel Mesothelioma Treatment
The U.S. Food and Drug Administration has granted orphan drug designation to ONCOFID-P for the treatment of malignant pleural mesothelioma, a step…